The molecular pathomechanism by which PS1/2 mutations cause AD is not entirely clear, although FAD-linked mutations are known to enhance the production of long, pathogenic Ass peptides through altering -secretase cleavage by PS complexes (reviewed in 58<IMG BORDER=1 WIDTH=8 HEIGHT=7 ALT="Go"
SRC="/icons/fig-down.gif">).
